Given their central role in managing protein homeostasis and stress responses, molecular chaperones are attractive therapeutic targets. Modulating chaperone activity could enhance the degradation of misfolded proteins or improve the cellular stress response, providing therapeutic benefits in toxicant-induced diseases. Small molecules that activate or inhibit chaperones are under investigation for their potential to treat diseases linked to protein dysfunction.
